Skin Disease in Methamphetamine Abuse
Launched by ASSIUT UNIVERSITY · Jul 31, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the skin problems that can occur in people who use methamphetamine, a powerful and addictive drug. The goal is to find out more about how this substance affects the skin and to identify specific skin diseases related to its use.
The trial is open to individuals aged between 18 and 45 who are currently using methamphetamine. However, pregnant or breastfeeding women, as well as those with long-term health conditions, will not be eligible to participate. Since the study is not yet recruiting, there will be more information available soon for those who might be interested. Participants can expect to undergo assessments related to their skin health and provide important information that could help improve understanding and treatment of skin issues linked to methamphetamine use.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients using methamphetamine
- Exclusion Criteria:
- • 1. Pregnant and lactating patients. 2. Patients with chronic diseases
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ahmed Shawkey gomaa, Lecturer
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported